View Item 

Show simple item record

The evolution of resistant Candida species in cancer centers See referenced original article on pages 2493–9, this issue
dc.contributor.authorRiddell, Jamesen_US
dc.contributor.authorKauffman, Carol A.en_US
dc.date.accessioned2008-06-04T14:36:30Z
dc.date.available2009-06-01T20:08:52Zen_US
dc.date.issued2008-06-01en_US
dc.identifier.citationRiddell, James; Kauffman, Carol A. (2008). "The evolution of resistant Candida species in cancer centers See referenced original article on pages 2493–9, this issue ." Cancer 112(11): 2334-2337. <http://hdl.handle.net/2027.42/58633>en_US
dc.identifier.issn0008-543Xen_US
dc.identifier.issn1097-0142en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/58633
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18412152&dopt=citationen_US
dc.description.abstractNo abstract.en_US
dc.format.extent58356 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.subject.otherLife and Medical Sciencesen_US
dc.subject.otherCancer Research, Oncology and Pathologyen_US
dc.titleThe evolution of resistant Candida species in cancer centers See referenced original article on pages 2493–9, this issueen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical School Ann Arbor, Michigan ; Fax: (734) 763-5793 ; Dr. Riddell has received grants from Bristol-Myers Squibb and Tibotec. ; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical School, 3120 Taubman Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-5378en_US
dc.contributor.affiliationumDivision of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical School Ann Arbor, Michigan ; Division of Infectious Diseases, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan ; Dr. Kauffman has acted as a member of the Speakers' Bureau for Merck, Pfizer, Astellas, and Schering-Plough and has received grants from Merck, Astellas, and Schering-Plough.en_US
dc.identifier.pmid18412152en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/58633/1/23465_ftp.pdf
dc.identifier.doihttp://dx.doi.org/10.1002/cncr.23465en_US
dc.identifier.sourceCanceren_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
23465_ftp.pdf
Size:
56.98KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.